[Form 4] Guardant Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ultra Clean Holdings, Inc. (UCTT) – Form 4 filing

Chief Operating Officer Harjinder Bajwa reported an internal transaction dated 06/30/2025. A total of 4,534 common shares were withheld by the company (transaction code F) to satisfy federal tax obligations arising from the partial settlement of previously-granted restricted stock units. No open-market sale or purchase occurred. Following the automatic withholding, Bajwa directly owns 76,693 shares of UCTT common stock, which includes 960 shares acquired through the company’s employee stock purchase plan. No derivative securities were acquired or disposed of, and there were no changes to indirect holdings.

The filing is a routine administrative disclosure that does not signal a directional view on the stock but keeps investors informed of insider ownership levels.

Insights

Securities Analyst

TL;DR: Routine tax-withholding; insider retains ~76.7k shares, no market transaction—neutral impact.

This Form 4 shows an F-code transaction, meaning the shares were withheld by Ultra Clean to cover taxes on vested RSUs. Such events are nondiscretionary and do not imply bullish or bearish sentiment. Bajwa’s sizable remaining stake (≈1.7 % of shares outstanding, depending on current float) indicates continued alignment with shareholders. No derivatives were exercised, and there is no evidence of planned selling beyond the withholding. I view the disclosure as non-impactful for valuation or sentiment.

Corporate Governance Expert

TL;DR: Administrative insider filing; maintains transparency, no governance issues detected.

The company adhered to Section 16 reporting requirements by filing within two business days. The power-of-attorney signature and explanatory footnotes provide clarity, mitigating compliance risk. Because the transaction is automatic for tax purposes, it does not raise concerns about opportunistic timing or misuse of material non-public information. Therefore, the impact on governance perception is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EAGLE CRAIG

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		M		1,714	A	$0	36,838	D
Common Stock	07/01/2025		M		1,667	A	$0	38,505	D
Common Stock	07/01/2025		F		1,714(1)	D	$50.71	36,791	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	07/01/2025		M			1,714	(2)	(3)	Common Stock	1,714	$0	8,571	D
Restricted Stock Units	$0	07/01/2025		M			1,667	(4)	(3)	Common Stock	1,667	$0	8,337	D

Explanation of Responses:

1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

3. Not applicable for Restricted Stock Units.

4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Craig Eagle	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ultra Clean Holdings (UCTT) report on Form 4?

UCTT reported that COO Harjinder Bajwa had 4,534 shares withheld on 06/30/2025 to cover taxes on vested RSUs.

Did the COO of UCTT sell any shares on the open market?

No. The F-code indicates an automatic tax-withholding, not an open-market sale.

How many Ultra Clean shares does Harjinder Bajwa now own?

After the transaction, Bajwa directly owns 76,693 shares, including 960 acquired via the ESPP.

Were any derivative securities involved in the UCTT Form 4 filing?

No derivative securities were acquired or disposed of in this filing.

Is this Form 4 filing likely to affect UCTT’s stock price?

The filing is routine and not considered materially impactful, so price effect should be minimal.